NEW YORK: Researchers have perfected a noninvasive “chemogenetic” technique that allows them to switch off a specific behavior in mice – such as voracious eating – and then switch it back on.

The method works by targeting two different cell surface receptors of neurons that Read More »

TUCSON: AstraZeneca is currently testing a potential Alzheimer’s disease treatment the company estimates could generate peak sales of $5 billion, if approved.

The demand for Alzheimer’s treatments creates blockbuster potential for the drug, but AstraZeneca has conceded the medicine has just a 9 percent chance Read More »

DALLAS: Neurotechnology company NeuroVigil has completed a second financing round in which the company issued equity securities at a pre-money valuation that was over two-and-a-half times the post-money valuations of the Series A financing rounds of Google and Facebook combined for less than 0.5% of Read More »

TULSA: Drugs with anticholinergic effects include tricyclic antidepressants, antihistamines, some muscle relaxants, some intestinal relaxants, treatments for dizziness and drugs that treat overactive bladder.

Between 10 and 40 percent of older adults take drugs with anticholinergic effects. We’ve known for a long time that these Read More »